Gene · 6012
Papers2,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Biophysics of Class A G Protein Coupled Receptors-Lipids Interactome at a Glance-Highlights from the A2A Adenosine Receptor. | Biomolecules | 2023 | 37371538 | PubTator, text mining | PubMed |
| Neurodevelopmental Model Explaining Associations between Sex Hormones, Personality, and Eating Pathology. | Brain Sci | 2023 | 37371339 | PubTator, text mining | PubMed |
| Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh®TM) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. | Curr Oncol | 2023 | 37366919 | PubTator, text mining | PubMed |
| Antisynthetase Syndrome With Paraneoplastic Antibodies. | Cureus | 2023 | 37366475 | PubTator, text mining | PubMed |
| Performance of a novel melting curve-based qPCR assay for malaria parasites in routine clinical practice in non-endemic setting. | Malar J | 2023 | 37349789 | PubTator, text mining | PubMed |
| A Case of Antisynthetase Syndrome in the Setting of SARS-Cov-2 Infection. | Cureus | 2023 | 37337554 | PubTator, text mining | PubMed |
| The ototoxic drug cisplatin localises to stress granules altering their dynamics and composition. | J Cell Sci | 2023 | 37334742 | PubTator, text mining | PubMed |
| The Potential of Artemisinins as Novel Treatment for Thyroid Eye Disease by Inhibiting Adipogenesis in Orbital Fibroblasts. | Invest Ophthalmol Vis Sci | 2023 | 37326592 | PubTator, text mining | PubMed |
| Sex and Brain: The Role of Sex Chromosomes and Hormones in Brain Development and Parkinson's Disease. | Cells | 2023 | 37296608 | PubTator, text mining | PubMed |
| Glioblastoma in pregnant patient with pathologic and exogenous sex hormone exposure and family history of high-grade glioma: A case report and review of the literature. | Surg Neurol Int | 2023 | 37292394 | PubTator, text mining | PubMed |
| Optimization of tumor-treating field therapy for triple-negative breast cancer cells in vitro via frequency modulation. | Cancer Cell Int | 2023 | 37287008 | PubTator, text mining | PubMed |
| Neutrophil-derived catecholamines mediate negative stress effects on bone. | Nat Commun | 2023 | 37277336 | PubTator, text mining | PubMed |
| Dominant aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models. | Front Neurosci | 2023 | 37274211 | PubTator, text mining | PubMed |
| Recessive aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models. | Front Neurosci | 2023 | 37274208 | PubTator, text mining | PubMed |
| Editorial: Purinergic pharmacology, Volume II. | Front Pharmacol | 2023 | 37261289 | PubTator, text mining | PubMed |
| Advances in Computational and Bioinformatics Tools and Databases for Designing and Developing a Multi-Epitope-Based Peptide Vaccine. | Int J Pept Res Ther | 2023 | 37251529 | PubTator, text mining | PubMed |
| A systematic review and individual participant data meta-analysis of gonadal steroid hormone receptors in meningioma. | J Neurosurg | 2023 | 37243565 | PubTator, text mining | PubMed |
| Simultaneous Occurrence of Hypospadias and Bilateral Cleft Lip and Jaw in a Crossbred Calf: Clinical, Computer Tomographic, and Genomic Characterization. | Animals (Basel) | 2023 | 37238140 | PubTator, text mining | PubMed |
| Neurotransmitters: promising immune modulators in the tumor microenvironment. | Front Immunol | 2023 | 37215113 | PubTator, text mining | PubMed |
| Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells. | Cell Rep | 2023 | 37200193 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6012/papers?page=17